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 Examining physiologic responses of cerebral blood flow (CBF) for subjects in 
challenging situations requires development of new technology.  Challenging 
circumstances include strenuous physical activity, intensive care, and surgical procedures 
involving the head, neck and thorax.  Headset technology to employ transcranial Doppler 
(TCD), which is commercially available, fails to meet several requirements for 
monitoring in these situations.  These requirements include stable signal acquisition, non-
interference with other physiological monitors, ability to fit all head sizes including 
infants and children.  The design and development of a novel TCD headset was 
performed to meet these requirements.  The new device theoretically allows the user to 
use TCD to challenging situations (e.g. cardiac surgery, pediatric use, exercise study, and 
concussion study).  The fixation described is intended to improve the quality of care and 
better inform physicians, research professionals, and clinicians on CBF parameters during 
long-term monitoring. 
 To test feasibility of the design, the prototype of this fixation device was tested in 
two populations: 1) healthy individuals and 2) stroke affected participants.  Both 
populations were engaged in exercise, cognitive, and dual task challenges in order to 
ascertain the ability of the new headset to provide stable signal acquisition.  Monitoring 
was successfully conducted while subjects were engaged in these tasks for a period of 
more than 20 minutes. 
 This novel TCD fixation system is currently being used in several ongoing 
investigations focused on determining changes in CBF in subjects recovering from stroke 
and concussion.  Further work is also planned to examine alterations in CBF in children 
and neonates who are undergoing corrective and palliative surgery for congenital heart 
disease. 
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Chapter 1 
Introduction 
1.1 Transcranial Doppler 
 Transcranial Doppler ultrasonography, commonly known as transcranial Doppler 
or TCD is the application of ultrasound to the measurement of cerebral blood flow for 
diagnostic purposes.  Knowledge of blood velocities as well as emboli (gas or particulate 
matter present in blood vessels) detection in specifically targeted regions of the brain may 
be gained through this technique.  TCD may be used in the measurement and diagnosis of 
embolism, hemorrhage, stenosis, and other problems within cerebral blood flow [1-3]. 
 Blood flow velocity distributions are calculated by measuring the phase shift of a 
high frequency sound wave as it returns to the piezoelectric transducer element with a 
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known speed of sound and measured angle of insonation.  This is greater discussed in 
section 2.2.4 [4-5]. 
 
1.2 Current State of TCD 
 TCD is relatively new application of Doppler technology. Its application has only 
been used clinically since around 1982 after Rune Aaslid presented the feasibility of 
using low ultrasonic frequency pulse Doppler signal insonation to measure changes in the 
characteristics of CBF through the skull in his publication Transcranial Doppler [6].  
Thirty years later, this thesis presents a new tool to be employed in future usage of TCD. 
Most of the work within the field of TCD is performed by positional mapping of the 
cerebral arteries using a hand-held transducer to determine blood velocities and vessel 
positions. This technique, performed manually, is effective in resting subjects for a 
limited period of time; generally less than 30 minutes.  Usefulness rests with the transient 
examination of flow characteristics in a specified cerebral blood vessel [6]. This thesis 
will address improvements in observation time that can be accomplished with new device 
described herein. 
 Due to limitations of marketed devices (such as instability during long term 
monitoring and discomfort with wear), there is much additional physiologic information 
that remains to be learned about cerebral blood flow during multi-task performance and 
physical activity. Recent studies have investigated various properties that may be 
determined by prolonged exposure of physiologic stimulus known to effect vasoreaction 
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and recording the magnitude of change [7].  What inhibits the application of TCD in 
many of these understudied environments is that current devices that hold the TCD probe 
in place without manual interference are cumbersome fixation devices. Additionally, 
these fixation systems are designed to work in adults in which head size is generally fixed 
to a narrow range of circumferences.  Future study with a stable fixation device could 
allow clinicians and researchers a greater understanding of the vessel reactivity that 
occurs during exercise states or challenging situations that require more than a few 
minutes of data acquisition [7]. 
 Limitations of TCD also occur because of the effect of angle on the calculation of 
the flow velocity. A false or artificially low blood flow velocity (BFV) may be calculated 
as a result of a high angle of insonation in relation to the direction of the blood vessel. 
Anatomic variation may also lead to altered BFV signals.  This can lead to the belief that 
difference in signals between paired cerebral arteries (i.e middle cerebral artery) is result 
of vessel pathology rather than to normal variation in symmetry typically encountered in 
the  population [5,9]. 
 Even with these limitations, TCD is an inexpensive and safe modality that 
provides high temporal resolution allowing real time signal acquisition and gives 
important clinical information that clinicians use in making important therapeutic 
decisions. With TCD technology, a clinician gains knowledge concerning the flow 
characteristics within the insonated vessel in real time and aids rapid decision making. 
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1.3 Problem Addressed 
 Using current TCD derived signals, the investigation of CBF is limited to short 
observation periods and in relatively non-challenging (i.e., resting, seated, or 
anesthetized) situations.  The hand-held stabilization technique proves to be nearly 
impossible to monitor cerebral arteries bilaterally.  It is also impractical to monitor even 
one artery for extended periods of time and maintain a stable signal during strenuous total 
body physical activity. Currently marketed fixation devices are relatively expensive, 
uncomfortable, difficult to place, and lack stability that would enable long-term 
monitoring of CBF. Many of the currently marketed mechanisms also cover large anterior 
and posterior regions of the head, making their clinical application nearly impossible 
during most surgical procedures in conjunction with necessary anesthetic management or 
cerebral and airway monitoring devices.  Fixation systems currently on the market are 
also only built for adults, excluding the ability to perform continuous TCD recording in 
infants and small children due to their smaller head size. 
 
1.4 Need 
 In order to view long-term physiologic responses to CBF in challenging 
situations, new technology is needed.  Physiologic responses of the basal cerebral arteries 
are influenced by many factors that can occur from the evolution of a disease process; 
during physical activity; or during a surgical procedure.  Physicians would welcome the 
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opportunity to measure these responses to better interpret the cause and effect of disease 
on cerebrovascular function, determine vascular reserve, or to aid diagnosis. 
 
1.4.1 The Problems with Current Transcranial Doppler 
Fixation 
 Current technology has many limitations that make its usage in a variety of 
challenging situations extremely difficult or clinically impractical.  Currently available 
transducer fixations are limited to use only on adults and could not be used during 
surgical procedures.  Current technology is expensive, bulky, difficult to situate, and 
composed of many parts, making it daunting for the technician and patient.  Much 
knowledge may be gained from monitoring BFV in a challenging environment; therefore 
simplifying the fixation technology is critical. 
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1.5 Motivation 
 As its core, biomedical engineering is the development of technology to be used 
for the improvement of medical care and treatment.  The philosophy of engineering 
design is the promotion of health.  As an imaging technology, TCD enables the 
noninvasive acquirement of real-time information that is low cost may be used for 
promotion of health.  Even within the limits of current TCD monitoring, it is a valuable 
diagnostic tool, useful in the early detection of vascular abnormalities from a variety of 
diseases that affect both brain tissue and blood vessels.  With the ability to expand TCD 
to more dynamic and challenging environments and expand the duration monitoring, 
considerable new knowledge can be gained concerning vascular responsiveness to normal 
physiologic stimulus, drugs, surgery and vascular or brain parencyhmal injury.  Therefore 
it is essential that a new fixation device be developed that allows for ease of use, stable 
signal acquisition and prolonged monitoring without creating undue interference to 
patient care or discomfort  
1.6 Objectives 
 The primary goal of this work is to develop a set of comfortable, easily fitted 
Doppler head set stabilizers for various subject populations to acquire reliable continuous 
cerebral blood flow (CBF) signals from the bilateral middle cerebral arteries (MCAs) 
while a subject is undergoing physical exercise and cognitive testing.  This necessitates 
product design and signal acquisition techniques that will ensure a reliable, adaptive, and 
previously unachievable input of blood velocity information during activity.  Such a 
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device could prove useful in pediatric, stroke, and concussion applications; these uses are 
recorded in chapter 6 
 The short-term goal of this work is to develop and construct an adult-sized novel 
fixation device, and demonstrate the feasibility for recording and analyzing TCD data in a 
population of 10 human subjects, with 3 recording sessions each, and analyze the signals 
in order to determine flow characteristics specific to physical activity and vascular 
condition. 
 
1.7 Thesis Organization 
 Chapter 2 is a comprehensive review of literature reviewing the anatomy and 
physiology of the brain, and the operating principles behind TCD.  Knowledge and 
understanding of the background information is essential to understand the proper 
application of TCD in cerebrovascular monitoring.  This background also points out 
unexplored topics and questions that remain to be answered on physiologic responses to 
consequences of injury, treatment and protection of the brain. 
 Chapter 3 is a commentary on the process of device development for a novel TCD 
headset.  This procedure is delineated to provide a clear understanding of the limitations 
of currently marketed devices and the rationale behind the creation of the novel fixation 
device.  This process is outlined in chronological device development organization. The 
engineering design is demonstrated by conventional engineering design tools such as 
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quality assessment, failure mode and effects analysis, Pugh analysis, and design for 
manufacture. 
 Chapter 4 describes a pilot study into the use of the novel fixation device and 
signal acquisition to determine activity.  This study used data gained through the 
participation of healthy individuals while undergoing physical activity and a cognitive 
challenge.  This investigatory study showed considerable promise for future studies using 
this novel TCD fixation device. 
 Chapter 5 describes the use of artificial neural networks for the analysis of data 
acquired with TCD.  This is a study with the primary aim of examining new methods to 
model blood velocity data. 
 Chapter 6 focuses on future applications of the novel fixation device, as well as 
methods of signal analysis and TCD application in challenging environments.  At the end 
of the chapter there is a review of safety considerations that need to be considered and 
understood while performing long-term studies with TCD. 
 Chapter 7 is a brief conclusion covering the past, present, and future of the novel 
TCD fixation device explained within this thesis. 
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Chapter 2 
Background and Literature Review 
 
2.1 Cerebral Blood Flow in the Circle of Willis 
 Blood exiting the heart leaves the aorta and branches off into the common carotid 
artery. The common carotid runs superior through the neck and enters the base of the 
skull, where it is then referred to as the internal carotid artery (ICA).  The ICA then 
supplies into the circle of Willis.  At the circle of Willis, the middle cerebral artery 
(MCA), anterior cerebral artery (ACA), and posterior cerebral artery (PCA) branch off to 
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supply blood to specific regions of the brain. Specifically, The MCA is responsible for the 
greatest volume of blood supply to the lateral regions of the brain, while the ACA and 
 PCA supply blood to the ventral and dorsal regions respectively [10]. 
 Variability within the circle of Willis often occurs in individuals.  Vessel path, 
primary connections, configuration, and vessel dimensions can vary considerably.  Some 
vessels of the circle of Willis be absent in some individuals.  A number of studies have 
variably estimated 46-82% of individuals have a circle of Willis that is considered within 
Figure 1: Circle of Willis, MCA region of insonation with handheld monitoring 
transducer. 
Adapted from: Newell, D.W. Transcranial Doppler. 1992; pp21 [10] 
 
INTERNAL CAROTID ARTERY 
ANTERIOR CEREBRAL ARTERY 
POSTERIOR CEREBRAL ARTERY 
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the normal range for classic anatomic features  as shown in Figure 1 [10]. 
 
2.1.1 Middle Cerebral Artery 
 The MCA has the largest diameter of the basal cerebral arteries.  Average vessel 
width ranges from 2.5-3.8mm.  Anatomically the MCA is in best alignment (parallel) 
with the TCD acoustic signal, providing the most accurate velocity measurement [10-11].  
When performing TCD, the larger artery diameter also allows for easier signal 
acquisition.  This vessel is also an ideal artery for studying contralateral flow differences, 
due to its very low anatomic variability compared to other vessels that comprise the circle 
of Willis. Asymmetry in size, diameter, or tortuosity of the MCA anatomy may occur 
within 20-25% of individuals. The variability however does not significantly compromise 
signal acquisition, reliability or interpretation [10-12]. 
The Middle Cerebral Artery's Role in Metabolism 
 Viewing the blood flow to lateral regions of the cerebral hemispheric cortex 
supplied by the MCA can provide great insight when investigating brain activity, as blood 
flow is strongly modulated by cellular metabolism.  With increased brain metabolic 
activity, CBF increases to the area in which that activity is occurring (CBF regulation 
factors described in section 2.1.2).  Positron emission tomography (PET) has shown these 
lateral regions to have hemispheric and area specific domains responsible for tasks 
requiring higher brain function.  These functions are involved in motion, speech, and 
cognitive activity [14].  
  
2.1.2 Flow Influencing Factors
 While metabolic activity is occurring
for changing blood flow.  T
factors that alter mean arterial pressure (MAP)
blood volume, cardiac output, and arterial vascular resistance
Figure 2: Factors influencing cerebral blood flow.
Blood Volume 
 Blood volume is simply the amount of blood in the circulatory system.  A typical 
70-kg adult will usually contain between 4.7 and 5 liters of blood.  This value varies on 
an individual basis and is controlled by the intake of water and regulated by the kid
 
 
, several internal mechanisms are responsible 
he following five sections explore several of t
; these factors, shown in Fig. 2, 
 [14].  
 
12 
he regulated 
include: 
 
neys.  
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Vasoactive medications such as antihypertensives and diuretics are major contributors to 
changes in blood volume.  In equation 1, blood volume is the fraction of plasma volume 
and the hematocrit [15].   
  (1) 
 
Cardiac Output 
 Cardiac output is controlled by heart rate, stroke volume, and vascular resistance.  
Heart rate is defined by the rate of depolarization of autorhythmic cells in the heart.  
These autorhythmic cells contain bundles of nerves.  Heart rate increases as physical 
activity increases as a result of increased metabolic demands.  Klabunde 2012 lists 
several factors that may cause an increase or decrease in heart rate that often are 
independent of metabolic demand.  These factors can be classified as either intrinsic or 
extrinsic.  Intrinsic factors are responsible for changes in heart rate by influencing the 
transduction of action potentials between cells.  Table 1 shows several extrinsic factors 
responsible for changes in heart rate.  Within a broad physiologic range, an increase in 
heart rate corresponds to an increase in cardiac output.  Stroke volume is related to 
ventricular emptying of blood.  The volume of ejected blood is determined by ventricular 
Table 1: Extrinsic Factors for Heart Rate Regulation 
INCREASING DECREASING 
Sympathetic Stimulation Parasympathetic Stimulation 
Muscarinic Receptor Antagonists Muscarinic Receptor Antagonists 
β-Adrenoceptor Antagonists β-Blockers 
Circulating Catecholamines Ischemia/Hypoxia 
Hyperthyroidism Sodium and Calcium Channel Blockers 
Klabunde R.E. (2012) Cardiovascular Physiology Concepts (2ed). pp23 [17]. 
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contractility and end diastolic volume (EDV).  EDV varies with venous return, venous 
constriction, respiration, or blood within the skeletal muscles [17]. 
 
Arterial Resistance 
 Arterial vascular resistance is the other major influencing factor responsible for 
blood delivery to the brain.  This factor results from change in vessel diameter within the 
pre-arteriolar level within every vascular bed and can be altered by many natural and 
vascular processes, biochemical stimulants and inhibitors.  These include hormones, 
metabolic waste products and intermediate metabolites, and sympathetic reflex control.  
Table 2 contains a list of hormones, vasoconstrictors and vasodilators.  During physical 
activity metabolic natural vasodilators are released from the effected tissue bed causing a 
decrease in arterial vascular resistance to enhance local blood flow and meet aerobic 
tissue needs for oxygen and nutrients.  Sympathetic reflex control is the relationship 
between the intravascular pressure and smooth muscles within the vessels and can be 
influenced remotely by a wide variety of physical activities and emotional responses.  As 
pressure changes within the vessel, smooth muscles mediate the pressure autonomously 
[15-16]. 
 
Venous Resistance 
 Perfusion occurs within capillaries in the brain, allowing metabolic activity and 
neuronal survival.  Metabolic waste and CO2 is then removed through the cerebral veins 
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Table 2: Chemicals Responsible for Vasoconstriction and Vasodilation 
CHEMICAL ROLE SOURCE CHEMICAL 
Vasoconstriction 
 
  
Norepinephrin 
(a-receptors) 
Baroreceptor reflex Sympathetic 
neurons 
Neurotransmitter 
Serotonin Smooth muscle 
contraction 
Neurons Neurotransmitter 
Vasopressin Increase Blood 
Pressure 
Posterior 
pituitary 
Neurohormone 
Angiotensin II Increase blood 
pressure 
Plasma 
hormone 
Hormone 
Vasodilation    
   Epinephrine (ß2-
receptors) 
Increase flow Adrenal  
medulla 
   Neurohormone 
 O2,CO2,H+,K+ Increase flow for 
metabolism 
Cell 
metabolism 
Paracrine 
   Nitric oxide (NO) Paracrine mediator Endothelium Paracrine 
Natriuretic peptides (ex. 
ANP) 
Reduce blood 
pressure 
Atrial 
myocardium, 
brain 
Hormone, 
neurotransmitter 
Silverthorn, D. (2007). Human physiology. (4 ed., p. 511). San Francisco, CA: Pearson. 
[14] 
resulting in return to the heart for disposal either in the lungs, kidneys or liver.  It is 
estimated that in a healthy individual 70% of venous blood return is carried through the 
jugular veins [16]. 
 
Medications 
 Prescription medications are responsible for various effects relating to CBF.  
When measuring CBF it is important to note the medications a subject may be taking, as 
they may directly or indirectly effect cerebral blood velocity as a result of altering 
vascular tone.  These prescriptions include, but are not limited to, hormones, statins, 
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antihypertensives, selective serotonin re-uptake inhibitors, diuretics, and warfarin.  As an 
example, many patients who suffer brain injury from ischemic stroke are taking several 
classes of these medications.  Statins are cholesterol reducing drugs that inhibit the 
production of cholesterols by deactivating HMG-CoA reductase in the liver [18].  Statins 
may affect CBF by lowering blood pressure [19].  Selective serotonin re-uptake inhibitors 
(SSRIs) are a class of antidepressants that operate by preventing the re-uptake of 
serotonin in neuronal synapses after release.  Serotonin increases triggering of pleasure 
receptors in the brain, but is also a powerful neurohormone responsible for 
vasoconstriction [20].  Diuretics lower blood pressure by allowing the removal of water, 
thus changing blood volume.  Lowering blood volume can potentially change CBF[16].  
Warfarin is a drug responsible for reducing the production of blood clotting proteins in 
the live thereby reducing flow resistance in the vessels [21]. 
 Medications can also alter heart rate.  To compensate for this factor in clinical 
studies during exercise the Borg scale was developed to assess heart rate by rating 
perceived exertion (RPE).   In short, a subject is asked after performing a physical task to 
rate their exertional effort on a scale of 6-20.  The low end of the scale refers to the level 
of exertion at rest; the high end refers to the perceived maximum exerted threshold.  An 
investigator can determine heart rate with relative precision by adding a zero to the 
numerical rating [22]. 
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2.1.3 Challenges of Exercise on Cerebral Blood Flow 
Plasticity and Neurologic Protection (Neuroprotection) 
 Brain plasticity refers to the ability of the brain to create new neuronal pathways, 
while neuroprotection is a strategy aimed at preventing brain injury to the brain.  Aerobic 
activity has been shown to be neuroprotective and helps promote plasticity of the brain. 
For example,  new signaling pathways in develop following in patients who suffer a 
cerebrovascular accident (CVA) through the production of brain derived neurotropic 
factor (BDNF) and insulin-like growth factor 1 (IGF1).  BDNF is secreted during 
physical activity and encourages neuron growth and development as well as the 
production of new synapses through cellular secretion after production in neuronal 
endoplasmic reticulum.  BDNF promotes long term memory.  IGF-1 is produced in the 
liver, after being signaled by the release of growth hormone from the pituitary gland.  The 
neuroprotective and healing effects of BDNF and IGF-1 are not related to the production 
of new blood vessels in the brain, but are related to the production of new neural 
pathways [23-24]. 
 Physical activity can also contribute to the neuroprotective and plasticity of the 
brain through the development of new blood vessels throughout the brain [24].  
Physiologic stress during exercise promotes the release of vascular endothelial growth 
factor (VEGF) and angiopoietin 1 and 2 [26-28].  These proteins promote vessel growth 
by enhancing endothelial cell adhesion and proliferation [29].  In clinical studies, these 
changes could be identified in serial TCD examinations over time demonstrating 
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improved vascular pulsatility and lowered resistance.  In theory, the pathologic 
consequences of cerebrovascular injury as a result of stenosis or occlusion could be 
modified through physical activity.  Current review of literature fails to produce 
information where TCD has been used in this specific instance which makes this an 
exciting query for future investigation during the rehabilitation period in subjects who 
have experienced a CVA. 
 Aerobic exercise could also preserve CBF in the elderly and other populations 
who have experienced a CVA and suffer concominant orthostatic intolerance or 
hypotension.  This population experiences lightheadedness and syncope resulting from a 
sudden change in posture.  Reflex vasoconstriction in the lower legs to preserve CBF is 
diminished and the subject experiences a critical drop in CBF which can induce transient 
symptoms.  Investigation of the benefits of drug therapy and exercise in preserving CBF 
during postural change in this population would also be an important area of study with 
significant potential [30-31]. 
 
Limitations on Investigation with Current Technology 
 Monitoring CBF changes with TCD is limited to a few commercially-available 
fixation devices.  These devices are difficult to place and do not allow near infrared 
spectroscopy (NIRS) monitoring for cerebral oxygenation on the forehead.  These 
devices may also influence CBF by being uncomfortable for the wearer.  Current 
technology is also poorly adapted for monitoring blood flow velocities in individuals 
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while they are performing aerobic activity due to lack of stability of the ultrasound 
transducers during the exercise period [32-33]. 
 
2.2 Transcranial Doppler 
2.2.1 Acoustic Windows 
 Ultrasound waves are affected by substantial differences in characteristic 
impedance of materials.  Characteristic impedance is the ratio of pressure to particle 
velocity in an ultrasonic wave.  Each tissue type has a specific speed at which sound 
travels through.  The speed of sound in a tissue is related to compressibility and density 
of the tissue.  Compressibility refers to the volume change in response to the sound wave 
and density in the mass present within a region.  Typical characteristic sound velocities 
and impedances are displayed in Table 3.  Air and bone create a relatively high reflection 
in the signal through its much higher relative acoustic impedance in comparison with 
other materials.   This can create a potential problem when attempting to insonate blood 
vessels when air or bone is in the path of the ultrasonic beam.  To overcome this problem,  
Table 3: Characteristic Acoustic Impedance 
BIOLOGICAL 
MATERIAL 
VELOCITY (m/s) ACOUSTIC IMPEDANCE (rayls) 
Water 1480 1.48x106 
Fat 1450 1.38x106 
Muscle 1580 1.7x106 
Blood 1570 1.61x106 
Bone 3500 7.8x106 
Air 330 400 
Velocity corresponds to the speed that sound travels through a specific biological material.  
Baumgartner RW (2006) Handbook on Neurovascular Ultrasound. 21;3 [34] 
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Figure 3: Acoustic Windows 
Transorbital window (A), Transtemporal window (B), Transforaminal window (C). 
Reproduced from Katz ML. Textbook of Diagnostic Ultrasonography. Mosby, St. Louis, 2001 © 2001 
Elsevier.http://www.wpclipart.com/signs_symbol/skull/Human_skull_side_view.png.html. Accessed 
November 2012 [35] 
 
 
the sonographer typically places a gel on the skin surface and the transducer is inserted 
on the skin over the acoustic window eliminating interference from air.  Using low 
frequency Doppler (1-2 Mhz) allows sufficient energy to pass through the bone and 
achieve adequate signal acquisition.  The most common acoustic windows used in TCD 
investigations  include the (A) transorbital (eye), (B) transtemporal (lateral skull), and (C) 
A 
B 
C 
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transaforminal (base of skull) windows. These windows are shown in Fig. 3.  Insonation 
of each of these windows allows for specific blood vessel interrogation [36]. 
 The transtemporal window provides for the greatest variety of vessel study and 
signal acquisition.  These vessels include the internal carotid artery (ICA), middle 
cerebral artery (MCA), anterior cerebral artery (ACA), and posterior cerebral artery 
(PCA).  This window also typically provides an optimal angle of insonation of the MCA.  
The transtemporal window is further subdivided into four regions superior to the 
zygomatic arch: frontal, anterior, middle, and posterior [6].  Some degree of initial 
difficulty in identifying the optimal window is witnessed when the operator is performing 
the first investigation.  Once the relationship of the insonated vessel to surface anatomy is 
identified and the optimal amount of gain and power is found, subsequent studies prove 
relatively simple to perform by the same operator.  This difficulty increases based on 
operator skill level and with age of subject as bone density continues to increase into 
adulthood [6, 34-36]. 
 2.2.2 Ultrasound Operation 
Mapping of the Cerebral Arteries 
 Freehand mapping of the basal cerebral arteries may be performed along the 
transtemporal window with a 1or 2MHz transducer.  Typical waveforms identified for the 
blood vessels viewed in the transtemporal window during mapping are shown in Fig. 4.  
In adults, the first step is to select an initial insonation depth in the range of 56-58mm.  At 
this level the sonographer may insonate the bifurcation of the ACA and MCA (Fig. 4, A) 
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[36].  The bifurication can be seen by the presence of positive and negative velocity 
signals corresponding to flow towards and away from the transducer.  Locating the 
optimum angle of the M1 branch of MCA (main arterial stem prior to bifurication of the 
vessel distally) at the M1 branch may be achieved by lowering the depth of insonation 
and tilting the transducer to reveal a maximum velocity (Fig. 4, B).  Insonation of the M1 
region is shown in Fig. 1. Continuing to lower the depth to a range of 30-40mm and 
tilting the transducer towards the superior region of the brain will reveal a lower velocity; 
this is the point at which the MCA branches off to form the M2 region (MCA 
bifurication) (Fig. 4, C).  Deepening the angle of insonation to ACA-MCA junction, 
raising the depth between 60-66mm and tilting the transducer ventrally will typically 
reveal a negative velocity; at this point the ACA may be located without MCA signal 
interference (Fig. 4, D).  The PCA may be located by increasing the depth of the signal 
and angling the transducer posteriorly. (Fig. 4, E) [6, 38]. 
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(A)  (B)  
(C)  (D)  
(E)  
Figure 4: Velocity waveforms of various 
arteries insonated within the 
transtemporal window 
(A) Bifurcation of the anterior cerebral 
artery and middle cerebral artery 
(B) M1 region of the middle cerebral 
artery 
(C) M2 region of the middle cerebral 
artery 
(D) Anterior cerebral artery 
(E) Posterior cerebral artery 
All waveforms from Rune Aaslid, 
TCDsimulator [47] 
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Velocity Characteristic Indices 
 Cerebrovascular reactivity can be measured using several different proxy indices.  
These calculations are found in Table 4 and are calculated using peak-to-peak flow 
velocity data [6, 37-40]. 
 
Table 4: Vascular Activity Indices 
INDEX NAME EQUATION 
 
Resistivity Index (RI) 
   
  
Pulsatility Index (RI)   
  
A:B Ratio (A:B) 
  
Systolic Mean Ratio (SM) 
 
Vs=Peak Systolic Velocity, Vd= Minimum Diastolic Velocity, 
Vm=Mean Velocity 
Units-(unitless)  
R. Aaslid, Transcranial Doppler Sonography. Springer, 1986 [6] 
 
 
 Changes in intracranial pressure (ICP) can be estimated by the calculation of 
pulsatility index [40].  Intracranial pressure describes the average pressure present inside 
the skull.  This force causes increased resistance to blood flow, affects perfusion of the 
brain tissue, and may ultimately lead to brain death if levels ablate global arterial blood 
flow.  Bellner et al. showed significant correlation was made between values of PI and 
ICP that were not dependent brain injury type or mechanism of cerebral insult [40]. 
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2.2.3 Current Methods and Limitations 
Functional TCD 
 Functional TCD is the clinical investigation of CBF during activation and 
metabolism within the brain in response to physiologic stimulus, drug introduction 
physical or cognitive challenge.  This method uses our understanding of cognitive 
psychology for the localization of blood flow to brain regions [41-42]. 
 Typical tasks involved in testing activation regions include cognitive challenges 
such as mathematical computation and tests of verbal fluency, or audio and visual 
stimulation.  Viewing these physiologic responses requires continuous monitoring 
(>2minutes) to view activation and return to baseline of arterial velocity [41-44].    
 Continuous monitoring to examine CBF for more than 120 cardiac cycles presents 
several challenges that must be addressed.  The standard TCD method of is performed by 
manual monitoring.  Manual monitoring is typically useful for recording flow data for 5 
to 50 cardiac but longer periods produce operator fatigue, leads to signal loss due to loss 
of interface from operator hand or subject head movements. Finally attempting to 
examine side-to-side variability during functional testing to record simultaneous signals 
from the right and left MCAs is nearly impossible to perform by one operator.  To 
perform continuous TCD recording, several transducer fixation devices have been 
developed and are currently marketed for this purpose.  With these devices there are 
significant limitations to in their design.  The third chapter in this thesis delves further 
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into this issue and shows the steps taken to design and implement a device designed to 
meet the challenges present in situations that would not allow for long-term recording 
with current technology [32-33].  
 
2.2.4 Spectral Doppler Principles 
 The Doppler effect is the change in frequency of a reflected signal that occurs as 
an object moves towards or away from a transmitted signal’s source.  This change in 
frequency is known as the Doppler frequency (fd) and is shown in equation 2.   
=	  
      (2) 
 The transmitted frequency (ft) is the frequency of ultrasound wave being applied.    
The received frequency (fr) is the reflected frequency to the transducer.  The Doppler 
equation is then used to determine the velocity of the target blood flow.  The angle of 
insonation (θ) of the vessel and the speed of sound are important factors in the calculation 
(c~1500m/s) [45-46]. 
      cos   (3) 
     (4) 
 The Doppler effect only truly occurs with continuous wave (CW) Doppler.  This 
is due to the nature of a signal being continuously transmitted and received as opposed to 
finite-length pulses.  CW Doppler is not used for most TCD applications due to 
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limitations in ability to record at a specific depth to ascertain the flow through a specific 
vessel.  Therefore only pulsed wave (PW) Doppler can be used for specific vessel 
location and precision  
 In commercial TCD systems, a PW Doppler uses center frequency of 2MHz.   The 
rate at which the signal is emitted and received is known as the pulse repetition frequency 
(PRF). [46]. 
 When a signal is received by the transducer it is immediately stored with a series 
of other pulses to build up a matrix of evenly-spaced (in time) signals.  The two 
dimensions of this matrix are “fast time” (actual single-pulse/echo direction) and “slow 
time” or “ensemble time” (pulse-to-pulse direction). The ensemble time may be seen as 
the acquisition axis on Fig. 5 and is scaled by the PRF [46].  After a certain number of 
these signals are acquired (typically 64-128), the range gate is set at a point on the fast 
time axis (representing depth of insonation) and the amplitude is recorded for each 
sample.  The Hilbert transform (equation 5) is then performed on this sample to calculate 
direction.  This calculation is performed by taking the PV (Cauchy principle value) and 
multiplying it by the integral of the function divided by the difference of x and y 
evaluated from negative infinity to positive infinity.  
   !  "# $ % 
&&
&'(
)
')  (5) 
 After the Hilbert transform, the fast Fourier transform (FFT) is then calculated on the 
packet of information.  The frequency information is then plotted on a spectrogram 
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(representation of spectral density changing over time) at its characteristic point in time. 
This process is then repeated over the period of time that monitoring occurs. 
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(A)  
(B)  
(C)  
 
Figure 5: Pulsed Wave Doppler of simulated blood flow at PRF=5000Hz 
Plot of a scatter field moving towards the transducer (A/B), Plot of range gate (C)  
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Chapter 3 
 Device Development of Transcranial 
Fixation for Challenging Situations 
 
3.1 Introduction 
 Measuring CBF during the process of rehabilitation, physical activity, and 
cognitive tasks can provide valuable that that could improve our understanding of the 
complex interrelationship between cerebral function and changes in cerebral blood flow.  
Application of TCD in this field could quickly broaden the collected data which could 
add new insights and knowledge of this interrelationship.  Investigators and clinicians 
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would then be able to investigate the potential for new technologies and drugs to restore 
brain function by manipulating CBF.   Additionally, researchers could also ascertain if 
monitoring serial blood flow measurements whether restoring normal physiologic 
coupling of CBF and metabolism would be a harbinger of eventual good outcomes.  
These lines of investigation are impeded by current headset designs which limit such 
study of blood flow during a physical activity or are cumbersome due to the numerous 
points of contact around the head.  The device that is described in detail throughout this 
chapter provides effective transducer support necessary for the continuous observation 
and measurement of cerebral blood flow during a physiologically relevant period of time. 
 The purpose of this chapter is to provide details on the new fixation device to be 
used to study Doppler monitoring of CBF using a standard clinical instrument (TCD), 
while human subjects are engaged in challenging situations.  Challenging situations, as 
stated previously, include: cardiac surgery, awake children, and exercise.  The instrument 
is constructed to enhance subject mobility without compromising signal acquisition and 
increase the time that continuous data may be acquired.  The constructed system is novel, 
and the thus acquired data would enhance our knowledge in this important field.  Fig.1 in 
chapter 1 shows an illustration of the insonated blood vessels and the transducer 
placement [47-49]. 
  This chapter addresses the several fixation devices that exist and their 
limitations that prevent their use in long-term monitoring in challenging, but clinically 
important situations.   
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3.2 Prior Art 
 There are several headset designs currently available; four of these designs are 
displayed in Fig. 6.  Most of this discussion focuses on two of these designs (B) and (D).  
The Lam Rack Device (A) in Fig. 6 is difficult to use during surgery given that it 
interferes with other medical devices such as NIRS or complicates the anesthesiologist’s 
view of the subject’s head during the procedure.  The DiaMon® (B) set would be 
unusable during cranial procedures because device interface with the scalp overlies the 
typical craniotomy sites (forehead and back of the head).  The Elastic Headband (C) also 
falls short because of the necessary head fixation overlying the surgical area.  The option 
that appears most viable is the adhesive (D), but analysis presented later in this chapter 
shows how it, as well as the DiaMon® (B) set, fall short of design parameters needed for 
measuring CBF during craniotomy. 
 The forehead and back of the head are anatomical areas needed for access during 
cranial surgery.  These regions are obstructed with portions of all the aforementioned 
headsets, with the adhesive holder being the only exception.  The forehead is typically 
needed for placement of instruments necessary for measuring brain oxygenation.  The 
back of the head is typically needed for a pad to rest the head.  In the event that cranial 
cooling would need to be performed, the entire cranium would need to be available for 
access. 
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(A) (B) (C)
 
(D)
 
(E)
 
(F) 
Figure 6: Current TCD Headset Technologies 
Lam Rack Fixation Device (A), DiaMon® (B), Elastic Headband (C), Adhesive (D) (Compumedics 2011), 
(E) Marc 600 (Pulse Medical 2007), (F) Robotic Probe (Delicate 2011). 
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  These four described devices are all commercial Compumedics/DWL products 
and use transducers that our research group proposes to utilize for the measurement of 
CBF. 
 Two other companies market headsets that are very similar to the DiaMon®, these 
include the Marc 600 (Fig. 6, E) made by Pulse Medical (Seattle, WA) and the Robotic 
Probe (Fig. 6, F) by Delicate (Nanshan District, Shenzhen, P.R.China) [51-52].  Both 
devices have a headset design that involves considerable scalp surface contact which 
precludes their use during cranial surgery. 
 
3.2.1 Technology Gap 
 Current TCD fixation devices are cumbersome to place, uncomfortable to wear, 
lacks consistent stability for continuous monitoring.  Marketed devices also place straps 
in the way of other monitors required for viewing changes in brain oxygen saturation. 
 Previous literature describes TCD monitoring as an art [34,36], describing the 
process of pinpointing arteries as a difficult task that requires considerable expertise.  
Widespread use in the clinical realm for continuous monitoring requires that strides need 
to be made with the design of a device that makes continuous TCD signal acquisition 
targeting a science. 
 For our concept to be successful of these issues need to be addressed as well as 
other constraints later mentioned in the morphological chart. 
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3.3 Design and Discussion 
3.3.1 Functional Requirements 
Table 5: Morphological Chart for Proposed Concepts  
NEEDS CONCEPT 1 CONCEPT 2 CONCEPT 3 
Signal 
acquisition 
Headband allows 
easy placement; 
orbital transducer 
holder allows easy 
application. 
 
Orbital transducer 
holder allows 
easy placement. 
Placement of 
device is 
performed with 
adhesive. 
Comfortable 
contact with the 
subject 
Padding around 
earcup and padded 
headband.
 
Padding around 
headset. 
Weight of device 
is transferred 
around adhesive 
region. 
Stabilize the 
transducer 
Articulating arm 
holds transducer; 
headband holds set 
in fixed position.
 
Straps 
surrounding head 
support transducer 
and hold device. 
 
Adhesive holds 
transducer. 
Non-interfering 
with monitoring 
devices 
Open forehead 
region for NIRS 
monitors.
 
Region around 
forehead is 
occupied with 
strap. 
Regions outside 
of adhesive 
region are open 
to monitor 
placement. 
 
    
 Table 5 shows several of the design requirements needed for filling the gaps of 
current technology to yield a more robust design with better opportunity for data 
acquisition.  The morphological chart helps put potential design ideas into perspective, 
organizing the concepts with each method of meeting functional requirements.  Fritz 
Zwicky identified this approach in 1969 [54].  Gregory Smith stated in his work, 
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Morphological Charts: A systematic exploration of qualitative design space, “A 
morphological chart in essence is a table of functions and solutions for each function” 
[55].  This technique may be seen as an organized ideation method and is a very useful 
engineering/design method.   Morphological charts are developed by defining a set of 
primary functions and identifying the operations necessary for meeting the functions for 
each concept [56]. 
 
 Concept 1 is a design developed to be fitted on the patient like a pair of 
commercial headphones with two articulating arms intended to hold the transducers in 
place.  Mentioned in the chart is a NIRS system, which represents a broad spectrum of 
cerebral oxygenation monitors that operate by adhesive near infrared pads that adhere to 
the forehead and scalp of a subject.  
 Concept 2 is a headset much like the DiaMon®, Marc 300 headset, or Robotic 
probe headset but with slight modification, removing the top strap and placing a strap 
around the head using the 2MHz transducer from the Compumedics set. 
 Concept 3 would be an adhesive transducer holder much like the adhesive device 
(Fig. 5, D). 
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3.3.2 Morphology 
 Early on in product design the conclusion was drawn that for a fixation to remain 
non-influential in blood flow due to added subject stress the device must be comfortable.  
Following that same thought, a device may generate less fatigue if it resembles a 
commonly used consumer device (ex. headphones). 
 
Functional Decomposition 
 A functional decomposition (seen in Fig. 7) was performed for the development 
of the novel fixation.  This process is conducted by breaking down the desired function 
into subfunctions.  Herbert Simon described this approach in his 1973 paper: “The 
 
Figure 7: Functional Decomposition of Transducer Holder 
TCD During a 
Challenging 
Environment
Allow 
Insonation of 
the Cerebral 
Arteries
Hold
Tight contact 
with skin
provide support 
for transducer
Stabilize 
Transducer
disallow 
transducer 
movement
Allow 
Adjustment
Allow 
movement to 
find 
window/signal
Must lock tight 
after signal 
aquisition
Provide Real 
Time Data 
Aquisition
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organization of complex systems” [58-59].  Fig. 7 delineates the functional 
decomposition required for TCD in a challenging environment.  This is performed by 
first identifying the task that needs to be performed and dividing it into organized 
subfunctions down to the simplest level. 
3.3.3 Product Specifications 
 The greatest specification to be met was reliable interrogation cerebral arteries 
using TCD during challenging circumstances.  Other specifications include proper 
support and stability necessary for long-term monitoring (>2 minutes) without 
movement. 
 
3.4 Concept 
3.4.1 Materials 
 Materials chosen for this device were based on several parameters.  Strength, 
tensile properties, chemical stability, and biocompatibility were deciding factors.  To 
determine parts and use, an Ashby diagram (Fig. 8) was employed.  The Ashby diagram 
is a commonly used graph for evaluating materials based on strength and toughness.  The 
chart chosen contains the copyright of Professor Mike Ashby. The site we retrieved the 
chart from allows reproduction for teaching and learning purposes [59].    
 Spring steel was chosen for the band for its tensile properties.  ABS plastic was 
chosen for the ear cup structure based on its ability to be printed with 3D printing 
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technology, its low expense with necessary stiffness, and ability of sterilization.  Foam 
with ethylene vinyl acetate (EVA) covering was chosen for the ear cup padding for its 
softness and ability to be cleaned [60].  The foam cushion on the top of the head also 
allows for stability, ease of sterilization, as well as additional comfort.   
 The prototype is to be built out of spring steel, ABS, foam, and EVA.  Originally 
parts were to be of plastic given the ease of molding and manufacture, but after viewing 
the Ashby diagram, many different conclusions were drawn as to why these are the 
materials of choice. 
 
Figure 8: Ashby Diagram 
Free Ashby Chart Download. Granta Design Limited 2011. 
http://www.grantadesign.com/news/archive/Ashbycharts.htm [59] 
40 
 
 
 
 
 The ABS plastic does not add to the relative weight of the head fixation, so it also 
does not add strain to the patient.  This material was chosen through careful study of the 
Ashby chart on stiffness being within limits acceptable for the application.  This material 
also fits within the cost constraint, being an inexpensive material that is easily accessible. 
 Biocompatibility is also a feature that must be considered with our device.  
Contact with the body occurs only with the skin and there is no blood interaction.  Most 
of the contact is made between the ultrasound gel and the body, so it is important that the 
user operates the device only with gel that meets industry standards for medical use.  
Toxicity of ultrasound gel is practically nonexistent and there are no known risks to gel 
application.  Irritation of the skin from contact with the EVA foam should not occur; EVA 
is a comfortable and commonly used material [60].  Since some subjects may have either 
scalp infections or otherwise are contaminated with potential pathogens, the device must 
be able to be easily sanitized to prevent disease transmission when the device is placed on 
other subjects. 
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3.4.2 Pugh Analysis 
Table 6: Non-Weighted Pugh Matrix 1 
FUNCTIONAL REQUIREMENTS ADHESIVE (D) 
DIAMON® 
(B) 
(DATUM) 
CONCEPT 
Tight contact with skin s s + 
Provide Support for transducer 
-
 
s s 
Stable s
 
s + 
Able to sterilize 
-
 
s s 
Allow adjustment 
-
 
s s 
Used in a challenging 
environment (i.e. surgery) 
s
 
s + 
SUM 
-3 0 +3 
s=same/meets requirement, -=fails to meet requirement, +=exceeds in 
meeting requirement 
 In order to determine whether or not the design was moving along in the right 
direction a Pugh Matrix test was conducted.  The Pugh Matrix was introduced in 1991 by 
Stuart Pugh in his book Total design: integrated methods for successful product 
engineering [62]. Pugh’s technique is used to rank options by degree of success in 
meeting functional requirements.  This test was done with two non-weighted matrices 
and concluded with one weighted matrix.  These three tests can be viewed in Tables 6, 7, 
and 8; Table 6 is the first Non-Weighted Pugh Matrix, Table 7 is the second Non-
Weighted Pugh Matrix, and Table 8 is the Weighted Pugh Matrix. 
 For the first matrix, the DiaMon® headset was chosen as the datum.  After 
analysis the novel fixation device design was then chosen to represent the datum.  After 
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conducting weighted testing, the novel fixation device represented a major improvement 
over current designs by a difference of 27 and 28 points. 
 
Table 7: Non-Weighted Pugh Matrix 2 
FUNCTIONAL REQUIREMENTS ADHESIVE (D) 
DIAMON® 
(B) 
CONCEPT 
(DATUM) 
Tight contact with skin 
- - s 
Provide Support for transducer 
-
 
s s 
Stable 
-
 
- s 
Able to sterilize 
-
 
- s 
Allow adjustment 
-
 
s s 
Used in a challenging 
environment (i.e. surgery) 
s
 
- s 
SUM 
-5 -4 0 
s=same/meets requirement, -=fails to meet requirement, +=exceeds in 
meeting requirement 
 
 
   
Table 8: Weighted Pugh Matrix 
FUNCTIONAL REQUIREMENTS WEIGHT ADHESIVE (D) 
DIAMON® 
(B) 
CONCEPT 
(DATUM) 
Tight contact with skin 3 - - s 
Provide Support for transducer 3 -
 
s s 
Stable 3 -
 
- s 
Able to sterilize 1 -
 
- s 
Allow adjustment 1 -
 
s s 
Used in a challenging environment (i.e. surgery) 5 s
 
- S 
SUM 
 -11 -12 +16 
s=same/meets requirement, -=fails to meet requirement, +=exceeds in meeting requirement 
 The Pugh matrix analysis affected the final design by realizing the shortcomings 
of prior art, thereby guiding the production of a device of different design from existing 
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technology.  These shortcomings led to the design of a head fixation that should be 
relatively comfortable, stable, easily adjusted, and worn in a challenging environment.  
 
3.4.3 Quality Function Deployment 
 The quality function deployment was first developed in 1970s by Yoji Akao to 
improve product design and decrease the amount of time needed for development.  This 
method has been applied by Honda Motors and many other manufacturing, design, and 
service areas.  Quality Function Deployment: Integrating Customer Requirements into 
Product Design [631], Akao’s book, mentions that there are several methods that may be 
used for improving product design and one such method is the house of quality.  
 A house of quality, a method of quality function deployment, was performed in 
Fig. 9.  As a result of this analysis, a better grasp may be gained on both correct design 
parameters and end-user requirements.  For this test, customer needs are composed into a 
list: 
- Support the transducer 
- Tight contact with skin 
- Durable-won’t break 
- Robust- always works right 
- Reusable 
- Light 
- Easy to use 
- Aesthetics 
- Disallows transducer movement when placed 
- Allows adjustment 
- Must lock tightly 
 
Then needs are compared with the design parameters: 
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- Length of arm 
- Diameter of headband 
- Center of gravity location 
- Force of headband 
- Material 
- Strength 
- Material type 
- Time to place on fixation device 
- Time to find CBF 
 
 
 These factors were then weighted and customer needs were evaluated to 
determine their relative importance for supporting the transducer and robustness of 
design.  Of all the design parameters, we found that the most important were weight, 
comfort, and material strength.  The house of quality analysis affected the final design by 
placing emphasis on the areas of design that carry the greatest importance. 
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Figure 9: House of Quality
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 3.5 Design for Manufacture and Assembly 
 Design for manufacture and assembly (DFA) is a method that has been used by 
engineers since the 1960s to optimize design by analyzing the difficulty of assembly of 
all the components.  This method focuses on avoiding tight tolerances and making the 
assembly of a product as simple as possible [53, 62-63]. 
 There are several areas to focus on when designing a product that can be easily 
manufactured.  Table 9 shows the DFA matrix for rating the parts of the design.  To lower 
the difficulty for manufacture and assembly, first, tight tolerances are to be avoided.  For 
the design of our concept all of the parts were designed to create as few tight tolerances 
as possible. 
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Table 9: DFA Matrix for Novel fixation Device 
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3.6 Failure Mode and Effects Analysis 
 Failure mode and effects analysis (FMEA) is performed to evaluate the outcomes 
associated with parts failure.  The rationale behind performing this technique is to prevent 
or reduce risk by taking into account the possibility of device failure [56,64].  
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 Table 10 shows the different failure modes as well as their consequences.  To 
start, the functional requirements were observed.  These include supporting the 
articulating arm, allowing movement of the transducer, and providing insonation of the 
region of interest.  This analysis also explored the consequences of failure.  
Consequences include discomfort or insonation of a region of no interest.  Both 
consequences of failure put neither the operator nor the patient in danger. 
Table 10: FMEA Analysis of Novel Fixation Device 
FUNCTION FAILURE FAILURE 
MODE 
CONSEQUENCES CAUSES DETECTION 
 
ACTIONS 
 
Provide support 
for transducer 
  
  
  
Assembly 
mismatch 
  
  
  
no support 
  
  
  
no measurement 
of blood flow 
  
  
  
Not connected 
to the 
headband 
Swap out Change 
headband 
no assembly 
b/w clamp 
base and 
groove 
Perform 
assembly 
Change 
arm 
no assembly 
b/w clamp and 
wing nut 
Perform 
assembly 
Change 
ear cup 
Screw threads 
stripped 
Perform 
assembly 
Change 
screw 
 Tight with skin 
  
Bent arm Articulating 
arm bent 
Uncomfortable Improper 
storage  
Swap out Change 
arm 
Assembly 
mismatch 
Wrong size 
for subject 
Uncomfortable Improper Ear 
cup size 
Swap out Change 
ear cup 
no 
movement 
no measurement 
of blood flow 
no assembly 
b/w arm and 
headband 
Perform 
assembly  
Change  
arm 
 Allow 
movement to 
find window/ 
signal 
  
 Assembly 
mismatch 
  
 Limited 
Movement 
Difficult to find 
signal 
track groove 
too small 
look Change 
the arm 
Less 
movement Uncomfortable 
Inaccurate 
threading of 
arm 
Perform 
assembly 
Replace 
arm 
Lock tight after 
signal 
acquisition 
  
 Wear 
  
Does not 
lock   Loss of signal 
Screw threads 
stripped 
Swap out Change 
screw 
Nut threads 
stripped 
Swap out Change 
nut 
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 The FMEA affected the final design by evaluating potential risk as theoretically 
low.  This analysis shows that the novel device is a safe fixation for the intended use of 
continuous TCD monitoring. 
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Chapter 4 
  Monitoring Cerebral Hemodynamics with 
Transcranial Doppler Ultrasound during 
Cognitive and Exercise Testing 
 
4.1 Abstract 
 An observational study was performed as a preliminary investigation into the use 
of TCD for recording cerebral hemodynamic changes during multiple tasks. TCD is a 
method of measuring cerebral blood flow (CBF) using ultrasound transducers in contact 
with the surface of the head. Using the maximum flow envelope of the Doppler spectrum 
returning from the middle cerebral artery (MCA), standard clinical flow indices can be 
calculated and displayed in real time providing information concerning perturbations in 
CBF and their potential cause. These indices, as well as flow velocity measurements, 
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have been long been recognized as clinically useful in measuring changes in responses to 
various stimuli that can be used to indicate cerebrovascular health. For this study, the 
pulsatility index (PI) and resistivity index (RI) were chosen since they indicate composite 
changes indicative of vasoconstriction and vasodilatation which are normal 
hemodynamic responses under appropriate conditions. 
 A total of eleven participants were recruited to take part in this study. Nine of 
these individuals had no known disability (Controls); two had experienced unilateral 
CVA in the tissue distribution of an MCA.    Maximum velocity envelopes of the spectral 
Doppler data were recorded using a fixation device designed to stabilize two ultrasound 
probes (2 MHz) to measure the CBF in both (left and right) MCAs.  These measures were 
performed separately while the subject performed four activities: 1) rest, 2) cognitive 
challenge, 3) cardiovascular exercise, and 4) simultaneous cognitive challenge and 
exercise. Cardiovascular parameters were calculated from the data by extracting 
maximum (Vs) and minimum flow velocities (Vd), PI, RI, and time signatures for each 
cardiac cycle. The data for all patients show significant changes in cardiovascular 
parameters between states of rest and exercise, as well as slight trends across time. 
Although the data are preliminary, they show the capability of Doppler spectral 
examination of the bilateral MCAs in patients with physical limitation performing 
cardiovascular exercise. The novelty of examining a population using dynamic exercise 
who before could not perform such exercise offers the opportunity to study the impact of 
exercise on global cerebral recovery in unilateral stroke with significant physical 
impairment. 
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4.2 Introduction 
 Monitoring cerebrovasculature function by TCD may be performed in order to 
determine vascular abnormalities.  Abnormalities detected may include attenuation of 
flow from increased intracranial pressure, vascular injury from vasospasm or vascular 
obstruction, and detection of cerebral emboli arising from cardiac or carotid origin. The 
technique has proven vital in surveillance of patients with sickle cell disease at risk for 
CVA [66]. This application has also proved useful in the intensive care unit for manual 
monitoring for analyzing perturbations of CBF from a variety of conditions including 
cardiac arrest, asphyxia, intracranial hemorrhage, head trauma, and brain death [67]. 
 The Doppler frequency shift, and thus CBF velocity reflect changes in response to 
the downstream effect of prearteriolar vessel diameter and blood flow. This signal 
envelope has several useful components for CBF analysis. These include peak systolic 
velocity (Vs), end diastolic velocity (Vd), mean velocity (Vm), pulsatility index (PI) and 
resistive index (RI) [38, 64-66].  These components are routinely used to classify normal 
from abnormal flow patterns. 
 Continuous monitoring of subjects receiving rehabilitative care presents a 
challenge due to the complications of prolonged (> 10 minutes) monitoring while 
exercising or during a cognitive challenge (due to the need for steady manual 
manipulation of the transducer). 
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Thus, one area that has not been systematically studied is the impact of functionally 
relevant exercise on the CBF of those recovering from a stroke. In this study, we 
demonstrate a novel combination of a TCD stabilizer, modified exercise equipment for 
rehabilitating patients, and real-time tracking of CBF parameters to analyze unique data 
not previously achievable. 
 
 
Figure 10: Velocity scaled to voltage 
A function of time for a sample four-second window envelope with maximum and 
minimum points for index calculation (Vs=55 cm/s, Vd= 22.5cm/s). 
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4.2.1 Elliptical Training 
 Elliptical Training was chosen for this application due to several factors.  These 
factors include low-impact exercise, full body movement, and ability to rapidly raise 
heart rate.  The modified elliptical trainer used was developed and housed at Madonna 
Rehabilitation Hospital’s Movement Science Center which affords the opportunity to 
study subjects with normal motor and gait function as well as those subjects with mild to 
severe abnormalities in which their motor control can be studies and maintained during 
study procedures. 
 Ideally, elliptical training places subjects at the least risk of physical injury during 
exercise, while allowing recording physiological information relative to high activity 
training. 
 The addition of this physical exercise creates a great challenge in data retrieval for 
CBF using TCD, thus a stable fixation device is essential for long-term monitoring during 
the task. 
 
4.3 Methods 
4.3.1 Data Collection 
 The TCD fixation device described in chapter 3 was constructed to keep the 
transducers in place. Device development was crucial in order to ensure a consistent 
Doppler signal could be maintained over a period of at least 20 minutes without 
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transducer movement (leading to loss or attenuation of signal) or discomfort to the study 
participant [70]. 
 Experiments were performed at Madonna Rehabilitation Hospital. Exercise tasks 
were performed on the ICARE, a modified motorized elliptical trainer designed to enable 
individuals with and without physical disabilities to engage in sustained cardiovascular 
exercise that simulates a walking-like movement pattern [73-74]. 
 Initially, the MCA location was identified through a manual freehand technique 
locating the vessel in relation to the scalp within each temporal window. The depth of 
insonation was chosen to be at least 1 cm above the interior carotid artery (ICA) 
bifurcation and without collateral interference from other vessels. Once MCA location 
was established, the fixation device was placed on the scalp and both MCA signals were 
reestablished. Stability of signal acquisition was assured by each subject performing slow 
rotatory axial and lateral head movements for approximately 30 seconds. Insonation of 
the bilateral MCAs was performed for all cognitive and physical tests to maximize 
robustness of signal and ensure uniform recording. The MCA for each cerebral 
hemisphere was chosen for three reasons: 1) primary supply to 70% of each cerebral 
hemisphere encompassing the primary locomotive, speech and cognitive centers of the 
brain, 2) ease of identification during signal acquisition and 3) low angle of insonation 
relative to other BCAs within the circle of Willis [10-12,75].  
 Data containing the raw envelopes were recorded using an X2 Multidop system 
and 2 MHz transducers (Compumedics, DWL Singen, Germany). A LabView virtual 
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instrument and NI-USB-6009 data acquisition system (National Instruments Corporation, 
Austin, TX) were connected to a personal computer in order to save the recorded 
envelopes. The tracing of the maximum of the Doppler spectrum is automatically 
performed by the X2 Multidop system and scaled from velocity to voltage corresponding 
to the pulse repetition frequency (PRF).  The PRF was set to either 6 or 7 kHz depending 
on the scaling required to keep the signal from aliasing. The approximate scale factor of 
voltage to velocity in this study is 32.4 for 7 kHz and 24.4 for 6 kHz, found empirically. 
Signal envelope data were recorded at a sampling frequency of 500Hz.  
 Recordings were performed on nine individuals without known disabilities 
(Controls: 5 male, 4 female; 19 to 30 years of age) and two adult females greater than 6 
months post unilateral left CVAs of the MCA with residual right hemiparesis (Strokes: 58 
year old with hemorrhagic stroke; 55 year old with ischemic stroke; independent 
ambulators without assistive devices but velocity and duration reduced).  
 To evaluate stability of blood flow indices, Controls participated in 3 sessions 
each separated by 3-5 weeks. Measures recorded from the Stroke group were then 
compared to these normative values. Measures of blood pressure (BP), heart rate (HR), 
and oxygen saturation (O2) were recorded to reduce the risk of adverse events during 
exercise. 
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4.3.2 Task Definition 
 Subjects performed four separate tasks while being monitored with TCD: 1) 
Resting, 2) Cognitive Challenge, 3) Exercise, and 4) Exercise plus Cognitive Challenge. 
The first task involved resting for two minutes in a controlled environment (room 
temperature, normal lighting, and no outside visual or auditory stimuli). The second task 
included an initial 30 seconds at rest, performing a cognitive-challenging task for 2 
minutes (i.e., subject instructed to name as many words possible starting with a specific 
letter of moderate difficulty, excluding proper names or separate tense [75]) followed by 
30 seconds of rest. After waiting a minimum of two minutes until the HR returned to 
resting condition, the third task was administered. The third task involved locomotive 
exercise on the ICARE trainer for a period of 2 minutes at a rated perceived exertion 
(RPE) of 13. A 30 second rest period was performed before and after the exercise. After 
waiting a period of at least 2 minutes or until HR returned to the resting rate the final task 
was administered. The fourth task included 30 seconds of rest, followed by 30 seconds of 
ICARE training, and then (while still exercising on the ICARE) the participant performed 
the cognitive task for a duration of 2 minutes using a different letter of similar difficulty. 
Recording of the bilateral MCA signals was performed during the final test until HR 
returned to resting condition [76-79]. 
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4.3.3 Data Analysis 
 Envelopes corresponding to the maximum velocity trace through each MCA were 
filtered with a 4th-order Butterworth IIR lowpass filter (fc = 10 Hz), then imported into 
Matlab, (MathWorks, Natick, MA) where an in-house algorithm was designed to 
automatically detect Vs and Vd values from beat to beat. The algorithm was designed to 
first pair Vs and Vd values belonging to the same systolic pulse, then calculate Vm, PI, 
and RI according to the pair.  Fig. 10 displays a typical, resting maximum velocity 
envelope and characteristic velocities. Calculations are displayed in equations 6-8 [5]. 
PI=
*+'*,
*-   (6) 
RI=
*+'*,
*+   (7) 
= *+.*,   (8) 
 Due to Vs and Vd occuring at non-uniform intervals, an interpolation filter 
(Matlab ‘interp1’) was used to linearly interpolate Vs and Vd according to the actual 
sampled frequency (500 Hz). Twenty-second epochs were extracted from the data 
according to the task using pre-recorded time intervals. The average value of Vs, Vd, Vm, 
PI, and RI were computed for each of these windows. Percent change calculations were 
performed between tasks. Each state change was analyzed along two separate 20 second 
windows belonging to subject state change within resting, resting to cognitive task, 
resting to exercise task, and resting to dual cognitive-physical task. These tasks and order 
were chosen to view changes in cerebral hemodynamics due to alterations in CBF and 
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downstream vascular resistance that can be reliably identified through monitoring the 
flow velocity envelope and its analysis [68]. 
 Cumulative data from the Control group’s right and left MCA were averaged. The 
average and standard deviation measurements were reported on the pooled percent 
change from baseline. Data from MCA of the involved (ipsilateral) and uninvolved 
(contralateral) hemispheres of the two Stroke participants were analyzed separately to 
discern potential variations arising from the impact of the injury. 
  
 
4.4 Results 
Figure 11: Average ratio of change values from resting to activity for Controls 
(Activity: 1-Resting; 2-Cognitive Challenge; 3
Challenge). 
 
 
-Exercise, 4-Exercise plus Cognitive 
60 
 
 
61 
 
 
 
4.4.1 Unaffected Individuals (Controls) 
 The ratio of change data for the Control group are displayed in Fig. 11. Two-sided 
t-tests revealed significant increase in all parameters when comparing the Resting vs. 
Exercise (p<<0.01), Resting vs. Exercise and Cognitive Challenge (p<<0.01), Cognitive 
Challenge vs. Exercise (p<<0.01), and Cognitive Challenge vs. Exercise plus Cognitive 
Challenge (p<<0.01). No statistically significant differences were identified in the 
Control group between Resting vs. Cognitive Challenge and Exercise vs. Exercise plus 
Cognitive Challenge (p>0.05). 
  Table 11 displays the percent change within PI from Resting for each of the 
different tasks within the Control group during each of the three sessions. PI was chosen 
due to its representation of three characteristic variables within the signal (Vs, Vd, and 
Vm).  Within two 20 second windows of Resting data there appears to be little to no 
change in the PI. A very low decrease in PI was observed when performing the Cognitive 
Challenge task. A near 50% increase in PI was seen when introducing the Exercise task. 
Similarly a 50% increase in average PI was seen when introducing the Exercise plus 
Cognitive task. 
 
4.4.2 CVA Participants 
 Within the group of two MCA stroke participants, percent changes occur 
differently from the unaffected individuals; these results are displayed in Fig. 12. In 
general, velocities decrease when tasks are introduced.  These velocity drops translate to 
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a very slight increase in the PI and RI parameters.  Vs, Vd, and Vm show a difference 
between the ipsilateral and contralateral regions.  This group of CVA participants is low 
in population, thus no definitive conclusions can be drawn. However, the data shows the 
ability to record bilateral TCD signals with this population.   
 
4.5 Discussion 
4.5.1 Stability/Placement/Discomfort 
 The preliminary use of the novel fixation device in this study showed a great deal 
of stability with very little need for signal relocation after the transducers were secured.  
The device did not fall off of any subjects at any time while engaged in seated procedures 
or in exercise tasks.  Monitoring was conducted over an average period of 30-40 minutes. 
 
Placement Time 
 One major designed advantage of using the novel fixation device is ease of 
placement and signal acquisition.  Of the 30 placements, headset positioning on the head 
occurred at an average of 13 seconds with a standard deviation of 6.56 seconds.  Signal 
acquisition required greater time than placement of the device for fine tuning the 
transducers to achieve optimum insonation of both MCAs.  This had an average value of 
391.5 seconds for bilateral insonation with a standard deviation of 299.7 seconds. 
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Headache/Perceived Discomfort 
 In this study there were three cases of perceived discomfort with wearing the 
device, but these were quickly alleviated by repositioning of the headset.  In this study 
there were no reported cases of headache. 
 Two subjects that had experienced an MCA stroke were excluded due to the 
inability to acquire a signal.  This inability to find the MCA was most likely due to 
ossification of the temporal window common to the age range of the subjects tested [6]. 
 
Table 11:  Average Percent Change Values of PI 
from Resting to Exercise of Each of the Test 
Sessions 
Activity Test Sessions 
Session 
1 
Session 
2 
Session
3 
Resting-Resting 2.75 1.61 9.7 
Resting-Cognitive -3.06 -1.31 4.85 
Resting-Exercise 52.40 51.50 54.39 
Resting-Cognitive 
with Exercise 
42.67 47.52 53.36 
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Figure 12: Average percent change values from Resting to activity for 
affected individuals post stroke 
(Activity: 1-Resting, 2-Cognitive Challenge, 3-Exercise, 4-Exercise plus 
Cognitive Challenge) 
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Physiologic Response 
 The cerebrovascular responses witnessed during cognitive challenge and exercise 
are considered normal physiologic responses and therefore can be used to assess the level 
of intact cerebrovascular regulation. Intact autoregulation is considered one of the 
fundamental physiologic functions of cerebral circulation [76]. Its disruption is 
considered an indicator of poor neurologic outcome at least in the short term.  Within this 
section there is discussion and results regarding the stroke population that are highly 
speculative due to the low population involved in this study.   
 Within the Stroke affected participants, percent changes did not follow the same 
pattern as in the Control group (Figs. 11, 12). Within the Stroke group, activity brought 
on a negative percent change in Vs and Vd from baseline. This result possibly could 
indicate an inability to augment cardiac output or appropriate peripheral vasomotor 
response to exercise from the cumulative effects of lisinopril, amlodipine and propranolol 
used in one patient. Another possible factor could be that both participants were 
deconditioned to exercise as a result of the protracted period of recovery from their acute 
brain injury.  
 The differences between stroke affected cerebral hemisphere [ipsilateral] and 
unaffected hemisphere [contralateral] (Fig. 12) indicates that differences in 
cerebrovascular autoregulation differ not only by stimulus but also by magnitude. The 
small number of affected subjects precludes definitive interpretation of our preliminary 
data, but does highlight the importance of monitoring CVA affected and normal 
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hemispheric CBF simultaneously when determining the effect of various rehabilitative 
activities on cerebral autoregulation.      
 Further study is needed in this population to determine if subjects with unilateral 
stroke mount similar cerebrovascular responses as compared to healthy participants over 
time. This is especially true in comparing cerebral autoregulation in the intact cerebral 
hemisphere to the injured hemisphere to determine if there are substantive differences. 
Another area of study could determine whether cerebral autoregulation can recover, or if 
rehabilitation measures influence neurologic outcome when this regulatory mechanism is 
not restored. 
 
4.6 Conclusion 
 This study has proven the feasibility of monitoring CBF in individuals with and 
without disabilities over extended periods of time during exercise and cognitive challenge 
tasks. The ability to examine subjects with cerebral injury during tasks that are essential 
to independent, healthy living is expected to provide valuable insights into the design of 
therapeutic training interventions. TCD monitoring during task assessment may provide 
essential information regarding the appropriate types and intensities of rehabilitation 
critical, not only to elicit optimal cognitive or physical function, but also to normalize 
cerebrovascular autoregulation. The next natural step from this observational study is to 
expand preliminary understanding of the hemodynamics occurring during physical and 
cognitive activity to a larger population of stroke survivors. Currently, progress is being 
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made in recording data from community dwelling stroke survivors as they undergo a 
structured physical rehabilitation program in order to view possible changes in CBF. 
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Chapter 5 
Classifying Cerebral Blood Flow by Fuzzy 
Clustering 
5.1 Purpose 
This study was performed to investigate the feasibility of applying a fuzzy 
clustering algorithm to CBF data recorded in healthy subjects.   Clustering was performed 
as a method of classifying resting from exercise data [90].  This method may provide 
possible decision making for defining TCD related values. 
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Potential use of this algorithm is to model CBF of CVA participants along with 
unaffected individuals.  This could be useful in detecting CBF changes after a CVA 
participant has performed a series of exercise related therapy treatments. 
 
5.2 Methods 
 Data collected using procedures described in Chapter 14 was used to develop a 
fuzzy inference system (FIS).  The steps, from training to testing, are shown in Fig. 13.  
Training data from the defragmented envelopes was then separated into two separate 
categories for analysis, training, and testing.  To train the fuzzy clustering algorithm, crisp 
data was grouped and defined to represent the flow conditions.  Data was assigned a 
category of 0,1, or 2.   These categories represented resting (0), cognitive (1), or exercise 
(2).  Fig. 14 displays data acquired from one subject for the resting, cognitive, and 
exercise tasks.  Within these signals it is expected that the time between resting and 
activity would have a different transient response due to age, vascular deconditioning, 
vessel injury, and medications.  The resting, cognitive, and exercise task group is 
named task set 1 and contains three classes.  The resting and exercise task group is 
termed task set 2 for the remainder of this section and contains two classes. 
 
  
Figure 13: Flow Diagram of Training and Testing the fuzzy inference system
 
 For this study testing of the FIS was performed on data 
cognitive task, and exercise.  These data sets then underwent calculation of PI
was calculated with Equation 4.  RI was then calculated using the same variables and is 
seen in Equation 6 (Equations 
 
 
correlating to only resting, 
6 and 7 are in section 4.3.3 
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 The first step performed before clustering involved looking at the variables 
chosen as inputs to justify their use [91].   These plots of the index value belonging to 
each individual sample may be seen in Figs. 15-16. 
 This preliminary analysis shows that there is a discernible difference between the 
PI and RI for the sets belonging to resting and exercise.  After viewing these differences 
this analysis was taken a step further by bringing in the cognitive PI and RI in relation to 
 
Figure 14: Velocity scaled to voltage 
A function of time for resting, cognitive, and exercise windowed envelopes with 
maximum and minimum points for index calculation. Time in seconds, amplitude in volts. 
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resting, cognitive task and exercise (task group 1).  These plots show a greater amount of 
overlap with the resting and cognitive than the resting and exercise (Figs 16-17). 
 
Figure 15: Plot of left side MCA PI and RI training data 
0 
1 
2 
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Figure 16: Plot of right side MCA PI and RI training data 
 
  
  Fuzzy c-means (FCM) was chosen to represent the clustering method due to its 
adaptability to represent several clusters with one data set [92].  The genfis3 function in 
Matlab conveniently uses FCM as its representative model. 
0 
1 
2 
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Figure 17: Membership for projection 
of clusters on PI input of task set 1 
Figure 18: Membership for projection of 
clusters on RI input of task set 1 
 
 
Figure 19: Membership for projection 
of PI input of task 2 
Figure 20: Membership for projection of 
RI input of task 2 
 
Setting Up and Testing the FIS 
 Using Matlab, a script was put together to load the indices represented in the 
training data and bring them into a genfis3 function.  Inputs were PI and RI.  Outputs 
were 0, 1, or 2 for the first iteration and 0 and 2 for the second iteration.  The output 
values were crisp and set to represent the group that each of the values were taken from.  
The number of clusters was set to be 3. 
PI 
PI 
RI 
RI 
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 The FIS structure was set as Sugeno, to evaluate and return with a constant 
variable for output [92-94].  The Sugeno method was chosen because this model required 
two inputs which it then takes the weighted average to compute one output.  Genfis3 
yielded a series of membership functions that may be seen in Figs. 17-18.  These 
membership functions represent the respective clusters that each of the two indices 
separate into, according to the assigned outputs.  Cluster 1 represents the region most 
closely corresponding to resting.  Cluster 2 falls most closely within performing a 
cognitive task.  Finally cluster 3 is closest to representing the exercise task. 
 In the membership functions for task set 2, seen in Figs. 19-20, cluster 1 
corresponds to resting; cluster 3 corresponds to exercise. 
 These functions are the rules for evaluating the test data and are responsible for 
the function of the FIS.   
The test data was set then input into the evalfis function for each of the two 
separate fuzzy inference systems (FIS).  These data sets consisted of 16,000 data points 
for the resting, cognitive, and exercise FIS and 800 data points for the resting and 
exercise FIS. 
 Error was calculated as the difference between the predicted value and the actual 
known value for each of the data points. The crisp output prediction was also created by 
performing a rounding function across the data sets to show membership in each of the 
groups. 
 
  
Figure 21: Predicted group membership with actual group membership for task 
set 1 
Figure 22: Predicted group membership with actual group membership for task 
set 2 
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5.3 Results and Discussion 
 Figs. 21 and 22 display the crisp output for the two test data sets.  The group 
numbers 0, 1, and 2 correspond to resting, cognitive, and exercise respectively.  The crisp 
output function was able to predict the correct membership with 33% accuracy in the 
resting, cognitive, and exercise group.  This output also predicted membership with 77% 
accuracy in the group belonging to resting and exercise. 
 This study was a test to see if fuzzy modeling techniques would be a viable option 
in classifying flow in healthy individuals.   Results yield a high level of classification, 
thus indicating fuzzy clustering as a potentially effective model. 
 Values for RI and PI are highly correlated making them difficult measures for 
modeling with fuzzy clustering.  After performing this testing it is recommended that 
future modeling be performed with other measures in addition to RI and PI. 
 The goal of future research on fuzzy signal analysis will be to refine the clustering 
technique and use this flow classifier with a population of stroke patients as they are 
undergoing rehabilitation as a method to show progress in cerebrovascular condition.  
TCD is a powerful tool in showing localized signals and being able to compare flow.  
Future studies should be performed to compare membership of the affected using the 
contralateral side as the training data set. 
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Chapter 6 
Future Opportunities 
and Ultrasound Safety 
 
6.1 Potential Applications 
6.1.1 Pediatric Use 
 The novel fixation device is designed to be sized to a wide range of head sizes 
including children of circumference measurements starting at 17 cm.  Table 12 shows a 
list of head measurements acquired by clinicians at Children’s Hospital Omaha (Omaha, 
Nebraska).  Dimensions taken at the hospital provide a more applicable measure for the 
headset device; making it available for use in a pediatric intensive care or during surgical 
procedure.  Ear cups have also been made to fit a wide range of study participants and are 
interchangeable with the headset. 
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Table 12: Cranial Measurements for TCD Headset 
AGE OF 
CHILD 
EAR CANAL TO 
TEMPORAL WINDOW (cm) 
CROWN 
MEASUREMENT (cm) 
OCCIPITAL MEASUREMENT  
(cm) 
1 week 2.0 20 24 
1.5 weeks 2.5 17 19 
2 weeks 2.0 17 24 
3 weeks 2.5 17 25 
5 weeks 3.5 22 24 
7 weeks 3.0 17 20 
3 months 2.0 18 23 
5 months 3.5 22 24 
5 months 3.5 26 23 
24 months 3.5 25 34 
21 months 3.8 32 34 
21 months 4.5 36 32 
132 months 3.6 28 28 
156 months 4.5 34 34 
AVERAGE 3.1714 23.6429 26.2857 
Data collected by Children’s Hospital Omaha over 4 month period in 2007. 
 There are many potential applications for TCD measurement using the novel 
fixation device.  Several of these pediatric applications are explained further in this 
chapter and include use during heart catheterization, heart surgery, and intensive care. 
 
Catheterization 
 Transcranial Doppler measurement during heart catheterization may help to 
observe emboli that are passing through the basilar cerebral arteries.  Emboli production 
is common in procedures performed in the heart catheterization laboratory and embolism 
is more prevalent in children.  Currently physicians are unable to monitor cerebral blood 
flow in this environment due to the lack of available fixation technology on the market.  
The novel fixation device is designed to allow monitoring in this environment [80-81]. 
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Congenital Heart Surgery and Postoperative Care 
 Several routine cardiac surgical procedures which are used to correct or palliate 
congenital heart disease including stent placement in stenosis vessels, cardiac valve repair 
or replacement, aortic arch repair or insertion of systemic to pulmonary conduits, patch 
closure of wall defects, and cardiopulmonary bypass can alter CBF.  Many of the subjects 
following these procedures can suffer significant alterations in CBF in the postoperative 
period as well leading to cerebral injury [82].  By using TCD during heart surgery and in 
the immediate postoperative period could provide clinically relevant information to the 
surgeon or the intensivist during surgery and in the post-operative period.  This 
information could affect the surgical procedure and cliical management that signficiantly 
attenuates CBF.  In the postoperative period, clinicans could monitor CBF and observe if 
therapeutic adjustments to augment cardiac function and tissue perfusion have beneficial 
or harmful effects on CBF. 
 
6.1.2 Cerebrovascular Accident 
 In 2010, 795,000 Americans experienced a new or recurrent CVA.  Of this 
population 610,000 are first attacks.  There are three types of CVA, intracerebral 
hemorrhagic, subarachanoid hemorrhagic, and ischemic stroke [81].  In Figs. 23 and 24 
the most commonly diagnosed CVA is due to ischemic stroke.  Intracerebral hemorrhage 
occurs when a vessel in the brain ruptures, blood leaks inside the cerebral cavity, and 
  
pressure damages the neurons
location may occur within the basal ganglia, cerebellum, brain stem, or cortex.  
Subarachanoid hemorrhagic stroke occurs when a 
the subarachnoid space (membrane between the brain and the skull) fills with blood
resulting buildup of pressure outside the brain may cause rapid loss of consciousness or 
death.  The third and most common CVA is ischemic stroke
to the brain is blocked, preventing nutrients and oxygen from being supplied 
[82]. 
Figure 23: Total CVA in United States 2010
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Figure 24: CVA type in United States 2010
 
Monitoring Blood Flow 
 Use of transcranial Doppler with the 
blood flow improvement during rehabilitation.  This new technology could be beneficial 
to clinicians who have an interest in 
patient while they are performing cardiov
 
6.1.3 Concussion and Traumatic Brain Injury
 Long-term monitoring of concussion or 
also be performed with the novel fixation
environments that require immedi
 
 
 
 
during Rehabilitation 
novel headset could allow for analysis of 
examining changes in cerebrovascular reactivity of a 
ascular exercise [85]. 
 
mild traumatic brain injury 
 device.  Application may be done in 
ate attention at the location of injury. 
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Athletics 
 Advanced concussion research in athletes has become a major focus in recent 
years.  The National Football League and National Collegiate Athletics Association have 
publically announced the need for research studying the effects as well as safe limits for 
concussion and mild traumatic brain injury (mTBI) [88-89]. 
 A significant opportunity for the understanding of sports related injury may be 
application of the novel fixation device.  Further research in cerebrovascular reactivity in 
the concussed brain may be performed on the sideline of sports play, reducing further 
brain injury or notifying medical professionals of an instance requiring medical attention. 
 
Military Applications 
 In recent years soldiers returning from the field of battle have been diagnosed 
with brain injury due to shockwaves associated with explosive devices.  Cerebrovascular 
reactivity may be monitored from the battle field to medical evacuation through the use 
of the novel fixation device which could be easily applied to the head of an injured 
soldier.  Medical information related to blood flow velocities could be quickly identified 
reducing damage and improving the quality of care [89].  
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6.1.4 Analysis of Blood Flow in Low Gravity 
 In zero gravity it is proposed that increased intracranial pressure can cause space 
adaptation syndrome.  In a hypothesis presented by Jennings in 1990 this is caused by a 
shift in cephalad fluid [94].  TCD can be used to view changes in intracranial pressure, 
and with the portability and easy placement of the novel fixation device TCD monitoring 
may be conducted in space.  
 
6.1.5 Analysis of TCD Signals 
 The novel fixation device is able to effectively monitor Doppler spectral data 
from the MCA during many exercise and postural changes without signal loss.  This 
ability enables the acquisition of data that may have a transient response from two 
different states, for example, from exercise to resting.  This data may also present 
information on orthostatic intolerance due to sit to stand postural change.  Data received 
during these tests may require new analysis techniques.  
 Most TCD analysis techniques are performed by viewing the maximum velocity 
envelope.  Examining the entire frequency spectrum may provide additional information. 
Emboli sizing and classification is currently not performed, but would be valuable 
information for clinicians.  Sizing or classification of emboli may be possible with the 
raw data, but would require investigation. 
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6.2 Safe Use of Ultrasound for Long Term Monitoring  
 With any imaging modality, there are certain safety concerns that must be 
addressed.  Ultrasound, as compared with all other modalities, is seen to be safe due to 
the fact that it deals with mechanical waves instead of electromagnetic radiation.  It does, 
however, present two possible risks to subjects; these risks are tissue heating and 
cavitation.  Heating is related to the tissue type, power of the machine, and area of signal 
focus.   
 TI=
/0
/,12  (9) 
 TI is the basic thermal index equation for source power (W0) of a diagnostic 
ultrasound system with a clearly defined source power required to raise the temperature 
of the target 1 degree Celsius (equation 9) [92].  The indices for heating are cranial 
thermal index (TIC), thermal soft tissue index (TIS), and thermal bone index (TIB).  TIC 
and TIS are the only indices commonly viewed when working with TCD and are seen 
respectively in equations 10 and 11 [95]. 
TIC=0.2578  9 #:;  (10) 
 W0, again, is the average power at the source in mW and A is the aperture area in 
cm2.  To calculate the heating index of soft tissue aperture an equation is to be used in 
applications where the aperture area < 1cm2 [96].  This TIS calculation may be performed 
for most TCD applications since the area of interrogation is typically less than 1cm2. 
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 TIS=
/0
<=0>? 
  (11) 
 For the above calculations, the ultrasound center frequency (fc) must be known.  
Decreasing the power of transmission to the lowest necessary intensity is a general 
procedure to be utilized.  To ensure safety, the World Federation for Ultrasound in 
Medicine and Biology (WFUMB) established the policy commonly known as ALARA 
standing for “as low as reasonably achievable” [95].  This guideline serves as a policy to 
be observed, limiting power and exposure of ultrasound transmission to the lowest 
amount necessary [95-96]. 
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Chapter 7 
Conclusions 
 The design and development of a novel TCD probe fixation headset was 
performed and explained within this thesis.  There is a need for long-term CBF 
information that was previously unable to be met with currently marketed devices 
(chapter 3).  The novel fixation that was developed to overcome the limitations present in 
many of the devices on the market.  This new device allows the user to apply TCD to 
various challenging situations such as cardiac surgery, awake children, exercise, and the 
ICU in brain injured subjects. 
 A prototype was built following the design.  This prototype was tested in a 
population of healthy individuals and stroke participants to view CBF changes in 
exercise, cognitive, and dual task situations.  Continuous monitoring was conducted 
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successfully in this population satisfying study requirements while subjects were engaged 
in tasks that would have not been possible to monitor using freehand examination. 
 Currently this headset is being used in an investigatory study to view changes in 
blood flow while subjects are engaged in vestibular balance activities.  This project is one 
potential use that may become a future measure of concussion and mTBI.  Analysis of 
blood flow related to rehabilitation of stroke patients is currently ongoing.  This study is 
designed to provide information about blood flow changes occurring as a CVA survivor is 
undergoing rehabilitation. 
 The application that originally launched this project was using TCD as a 
continuous monitoring for clinically relevant periods of time (30 -240 minutes) in adults 
and children in a challenging environment.  Challenging environments for children could 
include cardiac surgery or intensive care.  Collaboration between Children’s Hospital, 
Madonna Rehabilitation Hospital, the University of Nebraska Medical Center, and the 
University of Nebraska – Lincoln is currently underway to investigate the use of the 
novel fixation device.  This collaboration is aimed to lessen cerebral consequences of 
disease and medical interventions.  
89 
 
 
 
References 
[1] K. Kimura, M. Yasaka, K. Wada, K. Minematsu, T. Yamaguchi and R. Otsubo, 
"Diagnosis of middle cerebral artery stenosis by transcranial color-coded real-
time sonography." Am. J. Neuroradiol., vol. 19, pp. 1893-1896, 1998. 
[2] H. Markus, "Monitoring embolism in real time," Circulation, vol. 102, pp. 826-
828, 2000. 
[3] Y. Y. Vora, M. Suarez-Almazor, D. E. Steinke, M. L. Martin and J. M. Findlay, 
"Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm 
after subarachnoid hemorrhage," Neurosurgery, vol. 44, pp. 1237-1247, 1999. 
[4] R. C. Sanders and T. C. Winter, Clinical Sonography: A Practical 
Guide. Lippincott Williams & Wilkins, 2006. 
[5]  R. W. Gill, "Measurement of blood flow by ultrasound: accuracy and sources of 
 error," Ultrasound Med. Biol., vol. 11, pp. 625-641, 1985. 
[6] R. Aaslid, Transcranial Doppler Sonography. Springer, 1986. 
[7] B. Venkatesh, "Monitoring cerebral perfusion and oxygenation: an elusive 
goal," Crit Care Resusc, vol. 7, pp. 195-199, 2005. 
[8] G. Bashford and T. Xu, “Two-Dimensional blood flow velocity estimation using 
ultrasound speckle pattern dependence on scan direction and velocity,” 2012. 
[9] S. J. Dimmick and K. C. Faulder, "Normal Variants of the Cerebral Circulation at 
Multidetector CT Angiography1," Radiographics, vol. 29, pp. 1027-1043, 2009. 
[10] D. W. Newell and R. Aaslid, Transcranial Doppler. Lippincott Williams & 
Wilkins, 1992. 
[11] G. Wollschlaeger, P. B. Wollchlaeger, F. V. Lucas, V. F. Lopez, “Experience and 
result with postmortem cerebral angiography performed as routine procedure of 
the autopsy.” Am J Roentengenol, vol. 101, pp. 68-87, 1967. 
[12] S. Paul and S. Mishra, "Variations of the Anterior Cerebral Artery in human 
cadavers: A dissection study," J. Anat. Soc. India, vol. 53, pp. 15-16, 2004. 
[13] J. R. Anderson, Cognitive Psychology and its Implications. Worth Publishers, 
2009. 
[14] M. George, T. Ketter, P. Parekh, N. Rosinsky, H. Ring, B. Casey, M. Trimble, B. 
Horwitz, P. Herscovitch and R. Post, "Regional brain activity when selecting a 
response despite interference: an H215O PET study of the Stroop and an 
emotional Stroop," Hum. Brain Mapp., vol. 1, pp. 194-209, 2004. 
[15] D. U. Silverthorn and B. R. Johnson, Human Physiology. Pearson/Benjamin 
Cummings, 2004. 
[16] J. H. Wood, "Cerebral blood flow: physiologic and clinical aspects," 1987. 
[17] R. Klabunde, Cardiovascular Physiology Concepts. LWW, 2011. 
[18] A. Endo, "The discovery and development of HMG-CoA reductase inhibitors." J. 
Lipid Res., vol. 33, pp. 1569-1582, 1992. 
[19] P. Strazzullo, S. M. Kerry, A. Barbato, M. Versiero, L. D’Elia and F. P. 
Cappuccio, "Do statins reduce blood pressure? A meta-analysis of randomized, 
controlled trials," Hypertension, vol. 49, pp. 792-798, 2007. 
90 
 
 
 
[20] "Selective serotonin reuptake inhibitors (SSRIs),” mayoclinic.com, 2012, . 
[21] N. Guru, "Blood Viscosity " Ndnr, Mon, 08 Oct, 2012. 
[22] G. A. Borg, "Psychophysical bases of perceived exertion," Med. Sci. Sports 
Exerc., vol. 14, pp. 377-381, 1982. 
[23] C. Hyman, M. Hofer, Y. A. Barde, M. Juhasz, G. D. Yancopoulos, S. P. Squinto 
and R. M. Lindsay, "BDNF is a neurotrophic factor for dopaminergic neurons of 
the substantia nigra," Nature, vol. 350, pp. 230-232, 1991. 
[24] C. W. Cotman and N. C. Berchtold, "Exercise: a behavioral intervention to 
enhance brain health and plasticity,"Trends Neurosci., vol. 25, pp. 295-301, 2002. 
[25] C. W. Cotman, N. C. Berchtold and L. A. Christie, "Exercise builds brain health: 
key roles of growth factor cascades and inflammation," Trends Neurosci., vol. 30, 
pp. 464-472, 2007. 
[26] H. Van Praag, T. Shubert, C. Zhao and F. H. Gage, "Exercise enhances learning 
and hippocampal neurogenesis in aged mice," The Journal of Neuroscience, vol. 
25, pp. 8680-8685, 2005. 
[27] Y. H. Ding, J. Li, Y. Zhou, J. A. Rafols, J. C. Clark and Y. Ding, "Cerebral 
angiogenesis and expression of angiogenic factors in aging rats after 
exercise," Current Neurovascular Research, vol. 3, pp. 15-23, 2006. 
[28] J. E. Black, K. R. Isaacs, B. J. Anderson, A. A. Alcantara and W. T. Greenough, 
"Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in 
cerebellar cortex of adult rats," Proceedings of the National Academy of 
Sciences, vol. 87, pp. 5568-5572, 1990. 
[29] N. Ferrara and T. Davis-Smyth, "The biology of vascular endothelial growth 
factor," Endocr. Rev., vol. 18, pp. 4-25, 1997. 
[30] J. Park, Y. Nakamura, Y. Kwon, H. Park, E. Kim and S. Park, "The effect of 
combined exercise training on carotid artery structure and function, and vascular 
endothelial growth factor (VEGF) in obese older women," vol. 59, pp. 495-504, 
2010. 
[31] V. Gupta and L. A. Lipsitz, "Orthostatic hypotension in the elderly: diagnosis and 
treatment," Am. J. Med., vol. 120, pp. 841-847, 2007. 
[32] M. T. Magyar, A. Valikovics, D. Bereczki, I. Czuriga, and L. Csiba, “Transcranial 
Doppler monitoring in hypertensive patients during physical exercise,” 
Cerebrovasc Dis, vol. 12, pp.186-191, 2001. 
[33] K. Nedeltchev, M. Arnold, A. Nirkko, M. Sturzenegger, F. Rihs, R. Buhler, and 
H. P. Mattle, “Changes in blood flow velocity in the middle cerebral arteries 
evoked by walking,” J Clin Ultrasound, vol. 30, pp. 132-138, 2002 
[34] R. W. Baumgartner, Handbook on Neurovascular Ultrasound. Karger, 2006. 
[35] "TCD Ultrasonography, Insonation,” Iron Health Alliance, 2012. 
[36] H. A. Nicoletto and M. H. Burkman, "Transcranial Doppler series part II: 
performing a transcranial Doppler," Am. J. Electroneurodiagnostic Technol., vol. 
49, pp. 14-27, Mar, 2009. 
[37] I. Mikula, M. Periæ, A. Gopèeviæ, Z. Kusiæ, A. Balenoviæ and Z. Klanfar, 
"Consensus opinion on diagnosing brain death guidelines for use of 
confirmatory," Acta Clin Croat, vol. 44, pp. 65-79, 2005. 
91 
 
 
 
[38] H. A. Nicoletto and M. H. Burkman, "Transcranial Doppler series part III: 
interpretation," American Journal of Electroneurodiagnostic Technology, vol. 49, 
pp. 244, 2009. 
[39] J. P. Mohr, "Transcranial Doppler ultrasonography. Edited by Viken L. Babikian 
and Lawrence R. Wechsler, St Louis, Mosby-Year Book, 1993 323 pp, 
illustrated," Ann. Neurol., vol. 34, pp. 419-419, 1993. 
[40] J. Bellner, B. Romner, P. Reinstrup, K. A. Kristiansson, E. Ryding and L. Brandt, 
"Transcranial Doppler sonography pulsatility index (PI) reflects intracranial 
pressure (ICP)," Surg. Neurol., vol. 62, pp. 45-50, 2004. 
[41] S. Knecht, M. Deppe, E. B. Ringelstein, M. Wirtz, H. Lohmann, B. Dräger, T. 
Huber and H. Henningsen, "Reproducibility of functional transcranial Doppler 
sonography in determining hemispheric language lateralization," Stroke, vol. 29, 
pp. 1155-1159, 1998.  
[42] S. Duschek, R. Schandr. “Functional transcranial Doppler sonography as a tool in 
psychophysiological research.” Psychophysiology, vol. 40, pp. 436–454, 2003. 
[43] S. Knake, A. Haag, G. Pilgramm, J. Reis, K. M. Klein, H. Hoeffken, P. 
Bartenstein, W. H. Oertel, H. M. Hamer and F. Rosenow, "Ictal functional TCD 
for the lateralization of the seizure onset zone—a report of two cases," Epilepsy 
Res., vol. 62, pp. 89-93, 2004.  
[44] F. Rihs, M. Sturzenegger, K. Gutbrod, G. Schroth and H. Mattle, "Determination 
of language dominance Wada test confirms functional transcranial Doppler 
sonography," Neurology, vol. 52, pp. 1591-1591, 1999.  
[45] A. R. Lupetin, D. A. Davis, I. Beckman and N. Dash, "Transcranial Doppler 
sonography. Part 1. Principles, technique, and normal 
appearances."Radiographics, vol. 15, pp. 179-191, 1995. 
[46] D. Maulik, "Spectral Doppler: basic principles and instrumentation," Doppler 
Ultrasound in Obstetrics and Gynecology, pp. 19-34, 2005. 
[47] Transcranial Doppler Educational Software.  Educational Hemodynamic 
Software, http://www.transcranial.com/, 2010. 
[48] D. Popovic, M. Khoo and S. Lee, "Noninvasive monitoring of intracranial 
pressure," Recent Patents on Biomed. Eng.,vol. 2, pp. 165-179, 2009. 
[49] W. L. Nyborg, "Determining Risk to Subjects Exposure to Ultrasound," IRB: 
Ethics and Human Research, vol. 9, pp. 1-5, 1987. 
[50] Splavski, B., Radanović, B., Mužević, D., Has, B., Jančuljak, D., Kristek, J., et al. 
“Assessment of intra-cranial pressure after severe traumatic brain injury by 
transcranial doppler ultrasonography,” Brain Injury, pp. 1265-1270, 2012. 
[51] Fixations.  Compumedics DWL 2011, Inc. <http://www.dwl.de/, 2011. 
[52] Delicate.  Shenzen Deli Kai Electronics Co., Ltd. 2011. 
http://www.delicate.com.cn/english/products/Robotic%20Probe.html, 2011. 
[53] Pulse Medical. Pulse Medical 2007. 
http://pulsemedical.co.uk/product_info.php?cPath=1&products_id=30, 2007. 
[54] F. Zwicky, "Morphological astronomy," Berlin: Springer, 1957, vol. 1, 1957. 
[55] G. P. Smith, Morphological Charts: A systematic exploration of qualitatitve 
design space, 2007. 
92 
 
 
 
[56] C. A. Nelson, A Primer on Engineering Design of Biomedical Devices. Lulu, 
2009. 
[57] H. A. Simon, "The organization of complex systems," Hierarchy Theory: The 
Challenge of Complex Systems, pp. 1-27, 1973. 
[58] H. A. Simon, "The architecture of complexity," Proc. Am. Philos. Soc., pp. 467-
482, 1962. 
[59] Free Ashby Chart Download. Granta Design Limited 2011. 
http://www.grantadesign.com/news/archive/Ashbycharts.htm, 2011. 
[60] B. Rabinow, Y. Ding, C. Qin, M. McHalsky, J. Schneider, K. Ashline, T. 
Shelbourn and R. Albrecht, "Biomaterials with permanent hydrophilic surfaces 
and low protein adsorption properties," Journal of Biomaterials Science, Polymer 
Edition, vol. 6, pp. 91-109, 1995. 
[61] S. A. Leftly and D. C. Jones, Skin sensor device, 2008. 
[62] S. A. Pugh, Total Design: Integrated Methods for Successful Product 
Engineering. Addison-Wesley Pub. Co., 1991. 
[63] Y. Akao, Quality Function Deployment: Integrating Customer Requirements into 
Product Design. Productivity Press, 2004. 
[64] How to Market Your Device.  FDA 2011. 
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarke
tYourDevice/default.htm, 2011. 
[65] J. Jagannathan, D. M. Prevedello, V. S. Ayer, A. S. Dumont, J. A. Jane Jr., E. R. 
Laws, (2006).  Computer-Assisted Frameless Stereotaxy in Surgery: Clinical 
Material and Methods. Neurosurg Focus. 2006;20(2):E9 
[66] R. J. Adams, V. C. McKie, D. Brambilla, E. Carl, D. Gallagher, F. T. Nichols, S. 
Roach, M. Abboud, B. Berman and C. Driscoll, "Stroke prevention trial in sickle 
cell anemia."Control. Clin. Trials, vol. 19, pp. 110, 1998. 
[67] G. R. de Freitas, "Sensitivity of transcranial Doppler for confirming brain death: a 
prospective study of 270 cases," Acta Neurol Scand, vol. 113, pp. 426-432, 2006. 
[68] L. Pourcelot, “Diagnostic ultrasound for cerebral vascular diseases,” in 
[69] Present and Future of Diagnostic Ultrasound, I. Donald and S. Levi, Eds. 
Rotterdam, Holland: Kooyker Sci., 1976, pp. 141–147 
[70] A. D. Mackinnon, "Long-term ambulatory monitoring for cerebral emboli using 
transcranial Doppler ultrasound," Stroke, vol. 35, pp. 73-78, 2004. 
[71] T. R. Nelson, "Ultrasound biosafety considerations for the practicing sonographer 
and sonologist," J Ultrasound Med, vol. 28, pp. 139-150, 2009. 
[72] National Council on Radiation Protection and Measurements. Exposure Criteria 
for Medical Diagnostic Ultrasound, II: Criteria Based on All Known Mechanisms. 
Bethesda, MD: National Council on Radiation Protection and Measurements; 
2002. NCRP report 140. 
[73] C. A. Nelson, "Modified elliptical machine motor-drive design for assistive gait 
rehabilitation," Transactions of the ASME Journal of Medical Devices, vol. 5, pp. 
21001-21007, 2011.  
[74] J. M. Burnfield, "Impact of elliptical trainer ergonomic modifications on 
perceptions of safety, comfort, workout and usability by individuals with physical 
93 
 
 
 
disabilities and chronic conditions," Physical Therapy, vol. 91, no. 11, pp. 1604-
1617, 2011.  
[75] G. Bashford and T. Xu, "Lateral blood flow velocity estimation based on 
ultrasound speckle size change with scan velocity," IEEE Trans on Ferroelectrics 
and Freq. Cont., vol. 57, pp. 2695-2703, 2010.  
[76] Yogev-Seligmann, "How does explicit prioritization alter walking during dual 
task performance? Effects of age and sex on gait speed and variability," Phys 
Ther, vol. 90, pp. 177-186, 2010.  
[77] F.M. Ivey, "Improved cerebral vasomotor reactivity after exercise training in 
hemiparetic stroke survivors," Stroke, vol. 42, pp. 1994-2000, 2011.  
[78] T.K. Lin, "Interhemispheric comparisons of cerebral blood flow velocity changes 
during mental tasks with transcranial Doppler sonography," J Ultrasound Med, 
vol. 28, pp. 1487-1792, 2009.  
[79] S. Duschek, "Functional transcranial Doppler sonography as a tool in 
psychophysiological research," Psychophysiology, vol. 40, pp. 438-454, 2003.  
[80] D.W. Newell, "Comparison of Flow and Velocity During Dynamic 
Autoregulation Testing in Humans," Stroke, vol. 25, pp. 793-797, 1994. 
[81] C. Lund, R. B. Nes, T. P. Ugelstad, P. Due-Tønnessen, R. Andersen, P. K. Hol, R. 
Brucher and D. Russell, "Cerebral emboli during left heart catheterization may 
cause acute brain injury," Eur. Heart J., vol. 26, pp. 1269-1275, 2005. 
[82] J. R. Buck, R. H. Connors, W. W. Coon, W. H. Weintraub, J. R. Wesley and A. 
G. Coran, "Pulmonary embolism in children," J. Pediatr. Surg., vol. 16, pp. 385-
391, 1981. 
[83] D. A. Stump, A. T. Rogers, J. W. Hammon and S. P. Newman, "Cerebral emboli 
and cognitive outcome after cardiac surgery," J. Cardiothorac. Vasc. Anesth.,vol. 
10, pp. 113-119, 1996. 
[84] D. Lloyd-Jones, R. J. Adams, T. M. Brown, M. Carnethon, S. Dai, G. De Simone, 
T. B. Ferguson, E. Ford, K. Furie and C. Gillespie, "Heart disease and stroke 
statistics—2010 update," Circulation, vol. 121, pp. e46-e215, 2010. 
[85] "Ischemic Stroke | Internet Stroke Center " 2012 . 
[86] K. S. Wong, H. Li, W. W. M. Lam, Y. L. Chan and R. Kay, "Progression of 
middle cerebral artery occlusive disease and its relationship with further vascular 
events after stroke," Stroke, vol. 33, pp. 532-536, 2002. 
[87] "The issue of concussions in the NFL is not going away - ESPN " vol. 2012, . 
[88] "Concussions - NCAA.org ", 2012 . 
[89] C. Lawall, "Blast-Related Concussion," Traumatic Brain Injury, pp. 103-117, 
2012. 
[90] I.A. Wright, N.A.J. Gough, F. Rakebrandt, M. Wahab, J.P. Woodcock, Neural 
network analysis of Doppler ultrasound blood flow signals: a pilot study, 
Ultrasound Med. Biol., vol.23, pp. 683–686, 1997. 
[91] R. Yager and L. A. Zadeh, An Introduction to Fuzzy Logic Applications in 
Intelligent Systems. Norwell, MA: Kluwer, 1992.  
[92] D. Dubois and H. Prade, Fuzzy Sets and Systems: Theory and Applications. New 
 York: Academic, 1980.  
94 
 
 
 
[93] H. Seker, “Classification of electromyographic signals by using fuzzy classifiers,” 
 M.Sc. thesis, Dept. Electron. Comm. Eng., Istanbul Tech. Univ., Istanbul, Turkey, 
 1995.  
[94] T. Jennings, "Space adaptation syndrome is caused by elevated intracranial 
 pressure," Med. Hypotheses, vol. 32, pp. 289-291, 1990. 
[95] O'Brien WD and Ellis DS. Evaluation of the unscanned soft-tissue thermal index. 
IEEE Trans on Ultrasonics, Ferroelectrics, and Freq Cont., vol. 46, pp. 1459-
1476, 1999. 
[96] Evans DH. Physical and technical principles. Handbook on Neurovasc. 
 Ultrasound, vol. 21, pp. 1-18, 2006. 
